{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:49:14Z","timestamp":1775710154533,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore the clinical features and molecular genetic characteristics of epilepsy related to fever sensitivity caused by various types of gene mutations, and to analyze the relationships of genotype and clinical phenotype with clinical treatment efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study was conducted on 30 cases of children with abnormal genetic testing related to febrile sensitivity epilepsy treated in Wuxi Children\u2019s Hospital between June 2016 and April 2023. All 61 children who met the inclusion criteria underwent whole exome sequencing (WES); clinical features were compared between the 30 gene-positive patients and the 31 gene-negative patients. Genetic testing results and clinical data of the 30 positive cases were summarized and the children were divided into \u201ceffective\u201d and \u201cineffective\u201d groups according to the efficacy of clinical treatment for comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 30 gene-positive children, the onset of epilepsy occurred early, with 20 cases occurring within 1\u202fyear after birth, and 17 cases having developmental delay. Thirty cases of pathogenic genes related to epilepsy were detected with mutations in the\n                      <jats:italic>SCN1A<\/jats:italic>\n                      gene (13 cases),\n                      <jats:italic>PCDH19<\/jats:italic>\n                      (4 cases),\n                      <jats:italic>ADGRV1<\/jats:italic>\n                      (3 cases), and\n                      <jats:italic>CACNB4<\/jats:italic>\n                      (2 cases) as well as one case each of mutations in\n                      <jats:italic>SCN2A<\/jats:italic>\n                      ,\n                      <jats:italic>PRRT2<\/jats:italic>\n                      ,\n                      <jats:italic>CACNA1A<\/jats:italic>\n                      ,\n                      <jats:italic>CACNA1E<\/jats:italic>\n                      ,\n                      <jats:italic>CACNA1H<\/jats:italic>\n                      ,\n                      <jats:italic>KCNA2<\/jats:italic>\n                      ,\n                      <jats:italic>CHD2<\/jats:italic>\n                      , and\n                      <jats:italic>KIAA2022<\/jats:italic>\n                      , which was identified as a novel gene mutation related to epilepsy. The final diagnosis was 11 cases (36.7%) of Dravet syndrome, four cases (13.3%) of\n                      <jats:italic>PCDH19<\/jats:italic>\n                      -related epilepsy, four cases (13.3%) of generalized epilepsy with febrile seizures plus, one case (3.3%) of Epilepsy with myoclonic-atonic seizures, two cases (6.7%) of focal epilepsy, and eight cases (26.7%) of other types of epilepsy. There were differences between the \u2018effective\u2019 and \u2018ineffective\u2019 groups in the different pathogenic levels of American College of Medical Genetics and Genomics (ACMG) classification, mutation type (gene) and the onset age group (\u22641\u202fyear group) (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05), while there were no differences in sex, presence or absence of status epilepticus, and ion channel efficacy (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;gt;\u202f0.05). Comparison between the positive and negative groups revealed that patients in the positive group had a significantly earlier age at onset (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt;\u202f0.05), a higher frequency of status epilepticus (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt;\u202f0.05), and a higher rate of developmental delay after onset (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt;\u202f0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Febrile sensitivity-related epilepsy in children is primarily caused by\n                      <jats:italic>SCN1A<\/jats:italic>\n                      ,\n                      <jats:italic>PCDH19<\/jats:italic>\n                      , and\n                      <jats:italic>ADGRV1<\/jats:italic>\n                      mutations, manifesting mainly as Dravet syndrome and PCDH19-related epilepsy. The novel\n                      <jats:italic>KIAA2022<\/jats:italic>\n                      mutation expands the gene spectrum of this condition. Early age at onset, status epilepticus, and developmental delay are clinical red flags for genetic etiology, supporting early genetic testing in infants \u22641\u202fyear to guide precision treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1766799","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:10:39Z","timestamp":1775707839000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Genotype mutations and phenotypes of 30 cases with epilepsy related to fever sensitivity in children"],"prefix":"10.3389","volume":"17","author":[{"given":"Yanping","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, Affiliated Children\u2019s Hospital of Jiangnan University (Wuxi Children\u2019s Hospital)","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Children\u2019s Hospital of Jiangnan University (Wuxi Children\u2019s Hospital)","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingbo","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Children\u2019s Hospital of Jiangnan University (Wuxi Children\u2019s Hospital)","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Children\u2019s Hospital of Jiangnan University (Wuxi Children\u2019s Hospital)","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Hua","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Children\u2019s Hospital of Jiangnan University (Wuxi Children\u2019s Hospital)","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanshan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Laboratory, Affiliated Children\u2019s Hospital of Jiangnan University (Wuxi Children\u2019s Hospital)","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Emergency, Wuxi No.2 People\u2019s Hospital","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"ref1","volume-title":"Clinical diagnosis and treatment guidelines: epilepsy volume (2015 revised edition) [M]","year":"2015"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"858945","DOI":"10.3389\/fped.2022.858945","article-title":"Fever-associated seizures or epilepsy: an overview of old and recent literature acquisitions","volume":"10","author":"Pavone","year":"2022","journal-title":"Front Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.7504\/ek2015070602","article-title":"Clinical and molecular genetic study of epilepsy related to fever sensitivity","volume":"30","author":"Zhang","year":"2015","journal-title":"Chin J Pract Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/erm.2018.2","article-title":"The genetics and molecular biology of fever-associated seizures or epilepsy","volume":"20","author":"Deng","year":"2018","journal-title":"Expert Rev Mol Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3760\/cma.j.issn.2095-428X.2017.18.005","article-title":"Diagnosis and management of febrile seizures expert consensus","volume":"32","year":"2017","journal-title":"Chin J Appl Clin Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrneurol.2010.92","article-title":"Genetic evaluation and counseling for genetic evaluation and counseling for epilepsy","volume":"6","author":"Pal","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"591434","DOI":"10.3389\/fgene.2020.591434","article-title":"Clinical utility of exome sequencing and reinterpreting genetic test results in children and adults with epilepsy","volume":"11","author":"Jiang","year":"2020","journal-title":"Front Genet"},{"key":"ref10","first-page":"9","article-title":"The genetics of epilepsy in the clinical practice","volume":"83","author":"la De Torre","year":"2023","journal-title":"Medicina-Buenos Aire"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3760\/cma.j.cn511374-20200120-00041","article-title":"SCN1A gene variants among patients with Dravet syndrome","volume":"38","author":"Li","year":"2021","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1212\/WNL.0000000000003716","article-title":"Clinical and genetic factors predicting Dravet syndrome in infants with SCN1A mutations","volume":"88","author":"Cetica","year":"2017","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.braindev.2013.10.004","article-title":"Early clinical features and diagnosis of Dravet syndrome in 138 Chinese patients with SCN1A mutations","volume":"36","author":"Xu","year":"2014","journal-title":"Brain Dev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.gde.2020.06.012","article-title":"Disentangling the paradox of the PCDH19 clustering epilepsy, a disorder of cellular mosaics","volume":"65","author":"Gecz","year":"2020","journal-title":"Curr Opin Genet Dev"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pediatrneurol.2019.10.009","article-title":"PCDH19-related epilepsy syndrome: a comprehensive clinical review","volume":"105","author":"Samanta","year":"2020","journal-title":"Pediatr Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1111\/epi.14600","article-title":"Defining the electroclinical phenotype and outcome of PCDH19-related epilepsy: a multicenter study","volume":"59","author":"Trivisano","year":"2018","journal-title":"Epilepsia"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"E144","DOI":"10.3390\/children7090144","article-title":"Identification of Missense ADGRV1 Mutation as a Candidate Genetic Cause of Familial Febrile Seizure 4","volume":"7","author":"Han","year":"2020","journal-title":"Children (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/epi.13980","article-title":"ADGRV1 is implicated in myoclonic epilepsy","volume":"59","author":"Myers","year":"2018","journal-title":"Epilepsia"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.13362\/j.jpmed.202104006","article-title":"Autosomal incomplete dominant myoclonic epilepsy caused by ADGRV1 mutation: a case report and literature review","volume":"36","author":"Li","year":"2021","journal-title":"J Precis Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13041-019-0509-5","article-title":"Pathogenic Cav3.2 channel mutation in a child with primary generalized epilepsy","volume":"12","author":"Souza","year":"2019","journal-title":"Mol Brain"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3969\/j.issn.1000-3606.2020.11.005","article-title":"Clinical and genetic characteristics of a young child of epilepsy with myoclonic-atonic seizure caused by CACNA1H gene mutation","volume":"38","author":"Hu","year":"2020","journal-title":"J Clin Pediatr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"919996","DOI":"10.3389\/fped.2022.919996","article-title":"Whole-Exome Sequencing Identifies Novel SCN1A and CACNB4 Genes Mutations in the Cohort of Saudi Patients With Epilepsy","volume":"10","author":"Naseer","year":"2022","journal-title":"Front Pediatr"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ped4.12321","article-title":"Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy","volume":"6","author":"Feng","year":"2022","journal-title":"Pediatr Investig"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fnmol.2018.00208","article-title":"Chromatin remodeling proteins in epilepsy: lessons from CHD2-associated epilepsy","volume":"11","author":"Lamar","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.12372\/jcp.2023.22e0007","article-title":"Analysis of the clinical characteristics of epilepsy associated with CHD 2 gene variation","volume":"41","author":"Feng","year":"2023","journal-title":"J Clin Pediatr"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jmedgenet-2012-101406","article-title":"Role of PRRT2 in common paroxysmal neurological disorders: a gene with remarkable pleiotropy","volume":"50","author":"Heron","year":"2013","journal-title":"J Med Genet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3969\/j.issn.1000-3606.2019.08.015","article-title":"Clinical characteristics and genetic features analysis of PRRT2-associated paroxysmal","volume":"38","author":"Zhou","year":"2019","journal-title":"J Clin Pediatr"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng.3239","article-title":"De novo loss-or gain-of-function mutations in KCNA2 cause epileptic encephalopathy","volume":"47","author":"Syrbe","year":"2015","journal-title":"Nat Genet"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/hmg\/ddt187","article-title":"Loss of function of KIAA2022 causes mild to severe intellectual disability with an autism spectrum disorder and impairs neurite outgrowth","volume":"22","author":"Van Maldergem","year":"2013","journal-title":"Hum Mol Genet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1136\/jmedgenet-2016-103909","article-title":"De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy","volume":"53","author":"de Lange","year":"2016","journal-title":"J Med Genet"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1766799\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:10:49Z","timestamp":1775707849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1766799\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":30,"alternative-id":["10.3389\/fneur.2026.1766799"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1766799","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"article-number":"1766799"}}